Description

Carbamic acid, N-[(2,4-difluorophenyl)methyl]-, (3R)-3-[7-[[[(2,4-difluorophenyl)methyl]amino]carbonyl]-1,8-dihydro-9-hydroxy-1,8-dioxo-2H-pyrido[1,2-a]pyrazin-2-yl]butyl ester is a sophisticated, high-purity chemical intermediate designed for advanced pharmaceutical synthesis. This compound is critical for research and development in medicinal chemistry, particularly for constructing complex molecular architectures. It is primarily sought by pharmaceutical R&D teams and fine chemical manufacturers engaged in the development of novel active pharmaceutical ingredients (APIs).

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of novel, complex drug candidates, particularly in oncology and anti-infective research.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization for new therapeutic targets.
• API Development: Serves as a precursor in the multi-step synthesis of potential Active Pharmaceutical Ingredients (APIs).
• Bioconjugation & Probe Synthesis: Potential utility in creating labeled compounds or probes for biochemical and diagnostic research.
• Process Chemistry Scale-up: Supplied for process development and optimization from laboratory to pilot plant scale.
• Contract Research & Manufacturing (CRO/CMO): Essential raw material for organizations providing custom synthesis and manufacturing services.

Basic Information

Product Name	Carbamic acid, N-[(2,4-difluorophenyl)methyl]-, (3R)-3-[7-[[[(2,4-difluorophenyl)methyl]amino]carbonyl]-1,8-dihydro-9-hydroxy-1,8-dioxo-2H-pyrido[1,2-a]pyrazin-2-yl]butyl ester
CAS No.	2244161-73-5
Molecular Formula	C27H25F4N3O6
Molecular Weight	563.50 g/mol
Synonyms	(3R)-3-[7-[[[(2,4-Difluorophenyl)methyl]carbamoyl]-9-hydroxy-1,8-dioxo-1,8-dihydro-2H-pyrido[1,2-a]pyrazin-2-yl]butyl N-[(2,4-difluorophenyl)methyl]carbamate; 2H-Pyrido[1,2-a]pyrazine-2-butanol, 1,8-dihydro-9-hydroxy-1,8-dioxo-7-[[[(2,4-difluorophenyl)methyl]amino]carbonyl]-, 4-[[(2,4-difluorophenyl)methyl]carbamate], (3R)-; CAS 2244161-73-5; Difluorophenylmethyl carbamate derivative; Pyridopyrazine-difluorobenzyl carbamate intermediate; Advanced pharmaceutical building block 2244161-73-5.
EINECS	Contact for details

Quality Control

This product is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity suitable for pharmaceutical research. Quality is verified through comprehensive analytical techniques including HPLC, NMR, and mass spectrometry. A Certificate of Analysis (COA) detailing purity, identity, and impurity profiles is provided with each shipment to support your regulatory and R&D documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound is hygroscopic (moisture-sensitive) and should be handled under anhydrous conditions when possible to maintain stability and purity.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC)	Conforms to reference standard
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%
Heavy Metals	< 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.